These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15699113)

  • 41. T-cell mediated responses in a murine model of orthotopic corneal transplantation.
    Joo CK; Pepose JS; Stuart PM
    Invest Ophthalmol Vis Sci; 1995 Jul; 36(8):1530-40. PubMed ID: 7601633
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon-gamma knockout fails to confer protection against obliteration in heterotopic murine tracheal allografts.
    Batirel HF; Batirel S; Mitchell RN; Swanson SJ
    J Heart Lung Transplant; 2005 Jun; 24(6):658-64. PubMed ID: 15949724
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Airway epithelium is the primary target of allograft rejection in murine obliterative airway disease.
    Fernández FG; Jaramillo A; Chen C; Liu DZ; Tung T; Patterson GA; Mohanakumar T
    Am J Transplant; 2004 Mar; 4(3):319-25. PubMed ID: 14961983
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reduction of recipient macrophages by gadolinium chloride prevents development of obliterative airway disease in a rat model of heterotopic tracheal transplantation.
    Oyaizu T; Okada Y; Shoji W; Matsumura Y; Shimada K; Sado T; Sato M; Kondo T
    Transplantation; 2003 Oct; 76(8):1214-20. PubMed ID: 14578756
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hierarchical contributions of allorecognition pathways in chronic lung rejection.
    Chalermskulrat W; Neuringer IP; Brickey WJ; Felix NJ; Randell SH; Ting JP; Aris RM
    Am J Respir Crit Care Med; 2003 Apr; 167(7):999-1007. PubMed ID: 12446274
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of miRNA-155 in the immunopathogenesis of obliterative airway disease in mice induced by circulating exosomes from human lung transplant recipients with chronic lung allograft dysfunction.
    Bansal S; Itabashi Y; Perincheri S; Poulson C; Bharat A; Smith MA; Bremner RM; Mohanakumar T
    Cell Immunol; 2020 Sep; 355():104172. PubMed ID: 32707293
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Molecular mechanisms of chronic rejection following transplantation.
    Kuo E; Maruyama T; Fernandez F; Mohanakumar T
    Immunol Res; 2005; 32(1-3):179-85. PubMed ID: 16106068
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficient induction of minor histocompatibility antigen HA-1-specific cytotoxic T-cells using dendritic cells retrovirally transduced with HA-1-coding cDNA.
    Mutis T; Ghoreschi K; Schrama E; Kamp J; Heemskerk M; Falkenburg JH; Wilke M; Goulmy E
    Biol Blood Marrow Transplant; 2002; 8(8):412-9. PubMed ID: 12234166
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Induction of obliterative airway disease by anti-HLA class I antibodies.
    Maruyama T; Jaramillo A; Narayanan K; Higuchi T; Mohanakumar T
    Am J Transplant; 2005 Sep; 5(9):2126-34. PubMed ID: 16095491
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Tetrameric HLA class I-minor histocompatibility antigen peptide complexes demonstrate minor histocompatibility antigen-specific cytotoxic T lymphocytes in patients with graft-versus-host disease.
    Mutis T; Gillespie G; Schrama E; Falkenburg JH; Moss P; Goulmy E
    Nat Med; 1999 Jul; 5(7):839-42. PubMed ID: 10395333
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A novel MyD88 inhibitor attenuates allograft rejection after heterotopic tracheal transplantation in mice.
    Yang M; Chen G; Zhang X; Ding Z; Miao Y; Yang Y; Chen ZK; Jiang F; Chang S; Zhou P
    Transpl Immunol; 2019 Apr; 53():1-6. PubMed ID: 30472390
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rejection of tracheal allograft by intrapulmonary lymphoid neogenesis in the absence of secondary lymphoid organs.
    Wagnetz D; Sato M; Hirayama S; Matsuda Y; Juvet SC; Yeung JC; Guan Z; Zhang L; Liu M; Waddell TK; Keshavjee S
    Transplantation; 2012 Jun; 93(12):1212-20. PubMed ID: 23318304
    [TBL] [Abstract][Full Text] [Related]  

  • 53. PG490-88, a derivative of triptolide, attenuates obliterative airway disease in a mouse heterotopic tracheal allograft model.
    Leonard CT; Soccal PM; Berry GJ; Doyle RL; Theodore J; Duncan SR; Rosen GD
    J Heart Lung Transplant; 2002 Dec; 21(12):1314-8. PubMed ID: 12490278
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Anti-allergic agent tranilast decreases development of obliterative airway disease in rat model of heterotopic tracheal transplantation.
    Okada Y; Matsumura Y; Shimada K; Sado T; Oyaizu T; Sugawara T; Matsuda Y; Hoshikawa Y; Takahashi H; Sato M; Kondo T
    J Heart Lung Transplant; 2004 Dec; 23(12):1392-5. PubMed ID: 15607669
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Tacrolimus treatment effectively inhibits progression of obliterative airway disease even at later stages of disease development.
    Hollmén M; Tikkanen JM; Nykänen AI; Koskinen PK; Lemström KB
    J Heart Lung Transplant; 2008 Aug; 27(8):856-64. PubMed ID: 18656798
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Testicular immune privilege promotes transplantation tolerance by altering the balance between memory and regulatory T cells.
    Nasr IW; Wang Y; Gao G; Deng S; Diggs L; Rothstein DM; Tellides G; Lakkis FG; Dai Z
    J Immunol; 2005 May; 174(10):6161-8. PubMed ID: 15879112
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of T cell costimulation by VCAM-1 prevents murine graft-versus-host disease across minor histocompatibility barriers.
    Schlegel PG; Vaysburd M; Chen Y; Butcher EC; Chao NJ
    J Immunol; 1995 Oct; 155(8):3856-65. PubMed ID: 7561092
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Selective blockade of IL-15 by soluble IL-15 receptor alpha-chain enhances cardiac allograft survival.
    Smith XG; Bolton EM; Ruchatz H; Wei X; Liew FY; Bradley JA
    J Immunol; 2000 Sep; 165(6):3444-50. PubMed ID: 10975865
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Establishment of obliterative bronchiolitis in allo-trachea transplant model of rat and detection of its pathogenesis preliminarily].
    Qi Z; Yang DY; Wang R; Wang SZ; Ping YM
    Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):262-6. PubMed ID: 17502025
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Suppression of the obliteration process by ventilation in a mouse orthotopic tracheal transplantation model.
    Chen C; Zhang YZ; Zheng H; Xu BB; Gao W
    Transplantation; 2009 Jun; 87(12):1762-8. PubMed ID: 19543051
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.